ES2170318T3 - Derivados de 10,13,15-trioxatriciclo(9.2.1.1.9.6)-pentadecanona, procedimiento para su preparacion y medicamentos que contienen estos compuestos. - Google Patents

Derivados de 10,13,15-trioxatriciclo(9.2.1.1.9.6)-pentadecanona, procedimiento para su preparacion y medicamentos que contienen estos compuestos.

Info

Publication number
ES2170318T3
ES2170318T3 ES97118000T ES97118000T ES2170318T3 ES 2170318 T3 ES2170318 T3 ES 2170318T3 ES 97118000 T ES97118000 T ES 97118000T ES 97118000 T ES97118000 T ES 97118000T ES 2170318 T3 ES2170318 T3 ES 2170318T3
Authority
ES
Spain
Prior art keywords
derivatives
trioxatriciclo
pentadecanone
compounds
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97118000T
Other languages
English (en)
Inventor
Dagmar Holtje
Ulf Preuschoff
Emil Finner
Christian Eeckhout
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Products GmbH
Original Assignee
Solvay Pharmaceuticals GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharmaceuticals GmbH filed Critical Solvay Pharmaceuticals GmbH
Application granted granted Critical
Publication of ES2170318T3 publication Critical patent/ES2170318T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE DESCRIBEN UNOS DERIVADOS N - DESMETIL - N - ISOPROPILO ERITROMICINA - A - ESPIROACETAL DE ANILLO ESTRECHO DE FORMULA I, CON UNAS PROPIEDADES MOTILICAS AGONICAS ACTIVAS DESDE EL PUNTO DE VISTA GASTROINTESTINAL, Y SU PRODUCCION. SE DESCRIBEN [(1''R),2R,3S,4S,5R,6R,9R,11R,12R,14R] - 11 - (1'' HIDROXIPROPILO) - 2,4,6,8,11,14 - HEXAMETILO - 10,13,15 TRIOXATRICICLO - [9.2.1.1 SUP,9.6}] - PENTADECAN - 1 - ONA DERIVADOS DE FORMULA GENERAL I, EN DONDE R SUP,1} ES METILO O HIDROGENO. LA INVENCION TRATA TAMBIEN DE SUS SALES DE ADICION ACIDAS ESTABLES Y COMPATIBLES FISIOLOGICAMENTE.
ES97118000T 1996-10-24 1997-10-17 Derivados de 10,13,15-trioxatriciclo(9.2.1.1.9.6)-pentadecanona, procedimiento para su preparacion y medicamentos que contienen estos compuestos. Expired - Lifetime ES2170318T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19644195A DE19644195A1 (de) 1996-10-24 1996-10-24 10,13,15-Trioxatricyclo[9.2.1.1.·9·.·6·]-pentadecanon-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
ES2170318T3 true ES2170318T3 (es) 2002-08-01

Family

ID=7809858

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97118000T Expired - Lifetime ES2170318T3 (es) 1996-10-24 1997-10-17 Derivados de 10,13,15-trioxatriciclo(9.2.1.1.9.6)-pentadecanona, procedimiento para su preparacion y medicamentos que contienen estos compuestos.

Country Status (27)

Country Link
US (1) US5912235A (es)
EP (1) EP0838469B1 (es)
JP (1) JP4175682B2 (es)
KR (1) KR100466495B1 (es)
CN (1) CN1093133C (es)
AR (1) AR009809A1 (es)
AT (1) ATE211745T1 (es)
AU (1) AU726092B2 (es)
BR (2) BR9705143A (es)
CA (1) CA2219311C (es)
CZ (1) CZ291768B6 (es)
DE (2) DE19644195A1 (es)
DK (1) DK0838469T3 (es)
DZ (1) DZ2322A1 (es)
ES (1) ES2170318T3 (es)
HK (1) HK1010885A1 (es)
HU (1) HU222540B1 (es)
IL (1) IL121969A (es)
MX (1) MX9707974A (es)
NO (1) NO308362B1 (es)
NZ (1) NZ328979A (es)
PL (1) PL184693B1 (es)
PT (1) PT838469E (es)
RU (1) RU2181727C2 (es)
SK (1) SK283114B6 (es)
UA (1) UA44310C2 (es)
ZA (1) ZA979059B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998023629A1 (fr) * 1996-11-26 1998-06-04 Chugai Seiyaku Kabushiki Kaisha Composes de macrolides comportant une chaine a 13 elements, medicament les contenant et leur procede de preparation
PT1489090E (pt) * 2000-08-17 2006-05-31 Kitasato Inst Novos derivados de pseudoeritromicina
JP2003007917A (ja) * 2001-06-19 2003-01-10 Sanyo Electric Co Ltd 回路装置の製造方法
US6986882B2 (en) * 2002-01-17 2006-01-17 Astrazeneca Ab Therapy for functional dyspepsia
US7521420B2 (en) 2003-06-18 2009-04-21 Tranzyme Pharma, Inc. Macrocyclic antagonists of the motilin receptor
GB0611907D0 (en) 2006-06-15 2006-07-26 Glaxo Group Ltd Compounds
JP2009501199A (ja) 2005-07-12 2009-01-15 グラクソ グループ リミテッド Ｇｐｒ３８アゴニストとしてのピペラジンヘテロアリール誘導体
MX2008001211A (es) 2005-07-26 2008-03-24 Glaxo Group Ltd Derivados de bencilpiperazina y su uso medico.
CA2632779A1 (en) * 2005-12-08 2007-06-14 Pfizer Inc. Method for demethylating the 3'-dimethylamino group of erythromycin compounds
DE602007006019D1 (de) 2006-06-28 2010-06-02 Glaxo Group Ltd Für die behandlung von durch den gpr38-rezeptor vermittelten krankheiten geeignete piperazinylderivate
JP5684474B2 (ja) 2006-09-11 2015-03-11 オセラ セラピューティクス， インコーポレイテッド 胃腸の運動障害疾患の治療のためのモチリン受容体の大環状アンタゴニスト
RU2533116C2 (ru) 2009-02-27 2014-11-20 Раквалиа Фарма Инк. Оксииндольные производные, обладающие агонистической активностью в отношении мотилинового рецептора
WO2014156339A1 (ja) * 2013-03-25 2014-10-02 ゼリア新薬工業株式会社 食後期の胃運動亢進剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3725385A (en) * 1970-11-02 1973-04-03 Abbott Lab Process for the demethylation of 3-amino macrolides
US5106961A (en) * 1987-05-26 1992-04-21 Eli Lilly And Company Erythromycin ring-contracted derivatives
US4920102A (en) * 1988-04-18 1990-04-24 Eli Lilly And Company Method for treating gastrointestinal disorders
DE4200145A1 (de) * 1992-01-07 1993-07-08 Kali Chemie Pharma Gmbh 7,10-epoxy-oxacyclododecan-derivate, verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
NZ328979A (en) 1998-10-28
CN1093133C (zh) 2002-10-23
JPH10130297A (ja) 1998-05-19
BR9705157A (pt) 1999-09-28
CZ291768B6 (cs) 2003-05-14
JP4175682B2 (ja) 2008-11-05
ATE211745T1 (de) 2002-01-15
CA2219311C (en) 2007-09-04
CN1186808A (zh) 1998-07-08
US5912235A (en) 1999-06-15
NO974934D0 (no) 1997-10-24
SK283114B6 (sk) 2003-02-04
PT838469E (pt) 2002-05-31
HU222540B1 (hu) 2003-08-28
HK1010885A1 (en) 1999-07-02
HU9701660D0 (en) 1997-12-29
PL322802A1 (en) 1998-04-27
DE19644195A1 (de) 1998-04-30
KR100466495B1 (ko) 2005-05-27
CA2219311A1 (en) 1998-04-24
AR009809A1 (es) 2000-05-03
HUP9701660A2 (hu) 1998-05-28
KR19980032626A (ko) 1998-07-25
AU4278897A (en) 1998-04-30
IL121969A (en) 2000-06-29
DE59705964D1 (de) 2002-02-14
EP0838469A1 (de) 1998-04-29
NO308362B1 (no) 2000-09-04
RU2181727C2 (ru) 2002-04-27
MX9707974A (es) 1998-04-30
ZA979059B (en) 1998-05-07
DZ2322A1 (fr) 2002-12-28
UA44310C2 (uk) 2002-02-15
DK0838469T3 (da) 2002-03-18
PL184693B1 (pl) 2002-12-31
SK141997A3 (en) 1998-05-06
BR9705143A (pt) 2000-12-12
HUP9701660A3 (en) 1998-08-28
IL121969A0 (en) 1998-03-10
EP0838469B1 (de) 2002-01-09
NO974934L (no) 1998-04-27
AU726092B2 (en) 2000-11-02
CZ310697A3 (cs) 1998-06-17

Similar Documents

Publication Publication Date Title
ES2170318T3 (es) Derivados de 10,13,15-trioxatriciclo(9.2.1.1.9.6)-pentadecanona, procedimiento para su preparacion y medicamentos que contienen estos compuestos.
CY1116827T1 (el) Υψηλης καθαροτητας λιποπεπτιδια, μικκυλια λιποπεπτιδιων και διαδικασιες για την παρασκευη τους
ATE183744T1 (de) (3r,4r)--g(d)?6-tetrahydrocannabinol-7- carbonsäuren
NO893021D0 (no) Fremgangsmaate for fremstilling av en biologisk aktiv forbindelse, fr 901228.
ES2163613T3 (es) Derivados hidrofobos de taxano.
MX9305566A (es) Derivados de urea ciclicos, medicamentos que contienen estos compuestos y procedimientos para su preparacion.
BR9401484A (pt) Hidrazida de ácido 1h-indol-3-acético e formulação farmacêutica
EA199700267A1 (ru) Применение фумагиллола и его производных для приготовления антиинфекционных интестинальных препаратов и фармацевтическая композиция на их основе
HUP9900346A2 (hu) Avermektineket és depszipeptideket tartalmazó endoparazita ellenes hatású gyógyászati készítmények
HN1998000144A (es) Formulacion medicamentosa con liberacion controlada de sustancia activa.
ES2171722T3 (es) Nuevos derivados de la 5-o-desosaminil-6-o-metil-eritronolida a, su procedimiento de preparacion y su aplicacion a la preparacion de productos biologicamente activos.
KR920002151A (ko) 15-케토-프로스타글란딘 화합물에 의한 염증성 질환 치료
ES2172023T3 (es) Nuevos derivados tetrahidro-piridinicos sustituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2159843T3 (es) Derivados de 5,11-dihidrodibenzo(b,e)(1,4)oxazepina y composiciones medicamentosas que los contienen.
NO20006230D0 (no) Hyperforinderivater, anvendelsen derav og formuleringer inneholdende dem
AR014320A1 (es) Compuestos de (2r,3s,4s,5r,6r,10r,11r)-2,4,6,8,10-pentametil-11-acetil-12, 13-dioxabiciclo[8.2.1]tridec-8-en-1-ona, medicamentos que contienen estoscompuestos y procedimiento para la preparacion de dichos compuestos
ES2084585T3 (es) Derivados de la 6-oxo-piridazina, procedimiento para su obtencion y medicamentos que contienen estos compuestos.
SV1998000013A (es) Derivados de 5-aroilnaftaleno ref.-ran 4070\115
BR9813102A (pt) Derivados de ácido metilenobisfosfÈnico novos
ES2055365T3 (es) Derivados de alquilimino-2 benzotiazolina, sus procedimientos de preparacion y los medicamentos que les contienen.
ES2158309T3 (es) Fenilamidinas sustituidas, medicamentos que contienen a estos compuestos y procedimiento para su preparacion.
SE7906440L (sv) Pyridoxinderivat samt forfarande for framstellning av dem
FI864537A (fi) Kefalosporinderivat och foerfarande foer deras framstaellning.
NO903585L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksaziner.
DE69918974D1 (de) Perfluorierte ester von alkanoyl l-carnitin zur herstellung von kationischen lipiden zur intrazellulären verabreichung pharmakologisch aktiver verbindungen

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 838469

Country of ref document: ES